0.9781
Schlusskurs vom Vortag:
$0.9982
Offen:
$0.98
24-Stunden-Volumen:
74,197
Relative Volume:
0.02
Marktkapitalisierung:
$18.24M
Einnahmen:
$174.80K
Nettoeinkommen (Verlust:
$-8.85M
KGV:
-1.4202
EPS:
-0.6887
Netto-Cashflow:
$-4.37M
1W Leistung:
-0.72%
1M Leistung:
-27.01%
6M Leistung:
-22.06%
1J Leistung:
-75.42%
Nexalin Technology Inc Stock (NXL) Company Profile
Firmenname
Nexalin Technology Inc
Sektor
Branche
Telefon
(832) 260-0222
Adresse
1776 YORKTOWN, HOUSTON
Vergleichen Sie NXL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
NXL
Nexalin Technology Inc
|
0.9781 | 18.62M | 174.80K | -8.85M | -4.37M | -0.6887 |
|
ABT
Abbott Laboratories
|
122.55 | 210.84B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
92.70 | 137.17B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
353.80 | 133.55B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.77 | 127.71B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.92 | 48.33B | 5.88B | 1.34B | 799.60M | 2.3489 |
Nexalin Technology Inc Aktie (NXL) Neueste Nachrichten
What analysts say about Nexalin Technology Inc Equity Warrant stockEarnings Miss Alerts & Superior Capital Trading Plans - earlytimes.in
Market Overview: Will Nexalin Technology Inc stock outperform value stocksTrade Entry Report & Low Risk Investment Opportunities - BỘ NỘI VỤ
Nexalin Technology Stock Drop Looks Sharp, But How Deep Can It Go? - Trefis
Nexalin Technology Unveils New Investor Presentation on DIFS - TipRanks
Nexalin Technology, Inc. Unveils Advanced Neurostimulation Technology - TradingView
Will Nexalin Technology Inc. Equity Warrant stock reach Wall Street targetsTreasury Yields & Real-Time Stock Entry Alerts - Newser
Nexalin advances Alzheimer’s device after FDA meeting By Investing.com - Investing.com South Africa
Nexalin Technology and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Pocono Record
Nexalin Technology completes FDA Q-submission meeting for Gen-2 Sync - marketscreener.com
Nexalin advances Alzheimer’s device after FDA meeting - Investing.com
Nexalin Technology Completes FDA Q-Submission Meeting for - GlobeNewswire
Nexalin Technology Completes FDA Q-Submission Meeting for Gen-2 SYNC™ Neurostimulation Console in Alzheimer’s Disease Program - Sahm
Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on December 4 - markets.businessinsider.com
How Nexalin Technology Inc. stock trades before earnings2025 Trading Recap & Risk Controlled Stock Alerts - Newser
Nexalin Technology earnings missed by $0.01, revenue fell short of estimates - Investing.com Canada
Volume Summary: Is Nexalin Technology Inc. Equity Warrant stock supported by strong cash flows2025 Technical Patterns & Smart Swing Trading Alerts - BỘ NỘI VỤ
Investors in cash trouble should check out Nexalin Technology Inc (NXL) - Setenews
Nexalin Technology (NASDAQ:NXL) Rating Lowered to Sell at Wall Street Zen - Defense World
Nexalin Technology Inc. (NXL) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Is Nexalin Technology Inc. Equity Warrant stock near bottom after decline2025 Trade Ideas & Reliable Intraday Trade Plans - newser.com
Why hedge funds are buying Nexalin Technology Inc. stockEarnings Growth Report & Expert-Curated Trade Recommendations - newser.com
Price momentum metrics for Nexalin Technology Inc. explainedWeekly Market Report & Expert Curated Trade Setup Alerts - newser.com
Is Nexalin Technology Inc. Equity Warrant stock trading near support levelsEarnings Miss & Short-Term High Return Strategies - newser.com
Can Nexalin Technology Inc. stock withstand economic slowdown - newser.com
Trend analysis for Nexalin Technology Inc. this weekJuly 2025 Short Interest & AI Optimized Trading Strategy Guides - newser.com
Risk vs reward if holding onto Nexalin Technology Inc.Buy Signal & High Accuracy Buy Signal Tips - newser.com
Is Nexalin Technology Inc. stock attractive for retirement portfoliosJuly 2025 EndofMonth & Low Risk Entry Point Tips - newser.com
Will Nexalin Technology Inc. stock deliver better than expected guidanceQuarterly Market Summary & Safe Capital Allocation Plans - newser.com
Should you wait for a breakout in Nexalin Technology Inc.Trade Risk Summary & High Accuracy Trade Alerts - newser.com
How Nexalin Technology Inc. Equity Warrant stock performs in rate cut cyclesPortfolio Performance Summary & Expert Verified Movement Alerts - newser.com
How to monitor Nexalin Technology Inc. Equity Warrant with trend dashboardsJuly 2025 Selloffs & Short-Term High Return Strategies - newser.com
How analysts rate Nexalin Technology Inc. stock today2025 Volatility Report & Long-Term Growth Stock Strategies - newser.com
Will Nexalin Technology Inc. Equity Warrant stock benefit from automationJuly 2025 Highlights & AI Forecast Swing Trade Picks - newser.com
How to monitor Nexalin Technology Inc. with trend dashboardsIndex Update & Reliable Price Breakout Alerts - newser.com
Can Nexalin Technology Inc. stock double in next 5 years2025 Short Interest & Consistent Profit Alerts - newser.com
Can Nexalin Technology Inc. stock reach $100 price targetQuarterly Profit Review & Stock Portfolio Risk Control - newser.com
Detecting price anomalies in Nexalin Technology Inc. Equity Warrant with AIWeekly Trend Recap & Low Risk Entry Point Guides - newser.com
Statistical indicators supporting Nexalin Technology Inc.’s strength2025 Sector Review & Weekly High Conviction Ideas - newser.com
Published on: 2025-11-19 02:41:36 - newser.com
Finanzdaten der Nexalin Technology Inc-Aktie (NXL)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):